RAF1 Expression is Correlated with HAF, a Parameter of Liver Computed Tomographic Perfusion, and may Predict the Early Therapeutic Response to Sorafenib in Advanced Hepatocellular Carcinoma Patients

OBJECTIVES: Monitoring the early treatment effect of sorafenib in advanced hepatocellular carcinoma (HCC) patients is a diagnostic challenge. In a previous study, we reported the potential role of liver computed tomography perfusion (CTP) in the assessment of the response to sorafenib therapy in HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ninzi, Wu, Dong, Tang, Ming, Sun, Huichuan, Ji, Yuan, Huang, Cheng, Chen, Lingli, Chen, Gang, Zeng, Mengsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065427/
https://www.ncbi.nlm.nih.gov/pubmed/32190741
http://dx.doi.org/10.1515/med-2020-0024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065427/
https://www.ncbi.nlm.nih.gov/pubmed/32190741
http://dx.doi.org/10.1515/med-2020-0024

Ejemplares similares